By Malcolm Ritter
AP Science Writer 

US regulators let company test consumers for health risks

 


NEW YORK (AP) — For the first time, U.S. regulators have authorized a company to tell consumers directly about their individual genetic risk of certain diseases and conditions without involving a health care professional.

The California-based company 23andMe gained approval from the Food and Drug Administration to market genetic testing for risk of 10 ailments, including Parkinson's and Alzheimer's diseases.

The FDA, which in 2013 blocked the company from providing genetic health information, announced its decision Thursday.

The agency said the new tests may help people make decisions abo...



For access to this article please sign in or subscribe.

 

Reader Comments(0)

 
 

Our Family of Publications Includes:

Arc
Newsgram

Powered by ROAR Online Publication Software from Lions Light Corporation
© Copyright 2024